Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC

doi:10.3748/wjg.v9.i12.2681

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3543)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

409

HTML

2947

Figures (1-3)

187

Sum=3543

Dec 15, 2003 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (53)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Dec 15, 2003; 9(12): 2681-2685
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2681

Full Size Figure Download Figure

Figure 2 Ratio of metabolites to budesonide. 6β-OH-budesonide and 16α-OH-prednisolone serum levels were determined at the same time points as given in Figure 1. Metabolite-to-drug ratios were calculated and data are given as average ± SEM.

Citation: Geier A, Gartung C, Dietrich CG, Wasmuth HE, Reinartz P, Matern S. Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC. World J Gastroenterol 2003; 9(12): 2681-2685
URL: https://www.wjgnet.com/1007-9327/full/v9/i12/2681.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i12.2681